COMP <GO>
TRXB vs TECX // FORWARD P/E MULTIPLE
TRex Bio Inc. (NASDAQ) VS. Tectonic Therapeutic Inc. (NASDAQ) • 15-METRIC TALLY: TRXB 1
— TECX 1
■ METRIC PARITY
LAST: $13.74 (+1.63%) • MKT CAP: $377.1M
forward-pe
—
LAST: $19.78 (-3.51%) • MKT CAP: $386.7M
forward-pe
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TRXB VS. TECX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TRXB | TECX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -15.04% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 2/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.5 | 33.9 | +13.65 | TRXB | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $377.1M | $386.7M | -$9.6M | TECX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TRXB REV | TECX REV | TRXB GROSS % | TECX GROSS % | TRXB FCF | TECX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $0 | — | — | — | -$60.3M |
| FY 2024 | — | $0 | — | — | — | -$59.2M |
| FY 2023 | — | $0 | — | — | — | -$40.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TRXB // BETA —
TECX // BETA —